Assessment of primary prevention patients receiving an ICD - Systematic evaluation of ATP: APPRAISE ATP.

ABSTRACT:

Background

The value of antitachycardia pacing (ATP) in the overall cohort of primary prevention patients who receive implantable cardioverter-defibrillators (ICDs) remains uncertain. ATP success reported in prior trials potentially included a large number of patients receiving unnecessary ATP for arrhythmias that may have self-terminated owing to the prematurity of the intervention. Although some patients derive benefit from initial ATP in terminating rapid ventricular arrhythmias and thereby preventing shocks, there are limited data allowing us to identify those patients a priori.

Objective

The purpose of APPRAISE ATP is to understand the role of ATP in primary prevention patients currently indicated for ICD therapy in a large prospective randomized controlled trial

SUBMITTER: Schuger CD 

PROVIDER: S-EPMC8369290 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature